Application of balloon-occluded retrograde transvenous obliteration in the treatment of gastric varices

doi:10.3877/cma.j.issn.2095-5782.2022.04.017

Abstract

Abstract:

Gastric varices bleeding is one of the most serious complications of liver cirrhosis. Balloon-retrograde transvenous obliteration (BRTO) can effectively control variceal bleeding and improve liver function. In recent years, the status of BRTO clinical application in the world is gradually improving, which has become an interventional therapy comparable to transjugular intrahepatic portosystemic shunt (TIPS). However, due to the limitations of interventional instruments, drugs, and doctors ' proficiency, BRTO is not widely used in China, so that its clinical value is often ignored. This article reviews the origin and development, indications, contraindications, operation procedures, complications, and improved methods of BRTO.

Key words: Liver cirrhosis, Portal hypertension, Gastric varices, Treatment, BRTO

Qiwei Liang, Yi Huang, Yukuan Tang, Hanwei Chen. Application of balloon-occluded retrograde transvenous obliteration in the treatment of gastric varices[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2022, 10(04): 436-443.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjrfsxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5782.2022.04.017

https://zhjrfsxdzzz.cma-cmc.com.cn/EN/Y2022/V10/I04/436

References 63

[1]	Matei D, Crisan D, Procopet B, et al. Predictive factors of failure to control bleeding and 6-week mortality after variceal hemorrhage in liver cirrhosis–a tertiary referral center experience[J]. Archives of Medical Science: AMS, 2022, 18(1): 52.
[2]	Pfisterer N, Unger LM, Reiberger T. Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis[J]. World Journal of Hepatology, 2021, 13(7): 731.
[3]	Roccarina D, Best LM, Freeman SC, et al. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis[J]. Cochrane Database of Systematic Reviews, 2021, 4(4): CD013121.
[4]	Kanagawa H, Mima S, Kouyama H, et al. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration[J]. Journal of Gastroenterology and Hepatology, 1996, 11(1): 51-58.
[5]	Deliwala SS, Hussain M, Ponnapalli A, et al. Accelerated balloon-retrograde transvenous obliteration (BRTO): an effective tool in the Arsenal against isolated gastric varices (IGV)[J]. BMJ Case Reports CP, 2021, 14(9): e244405.
[6]	中华医学会肝病学分会. 肝硬化诊治指南[J]. 中华肝脏病杂志, 2019, 27(11): 20.
[7]	Northup PG, Garcia-Pagan JC, Garcia-Tsao G, et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases[J]. Hepatology, 2021, 73(1): 366-413.
[8]	Cornberg M, Tacke F, Karlsen TH. Clinical practice guidelines of the European Association for the Study of the Liver–Advancing methodology but preserving practicability[J]. Journal of Hepatology, 2019, 70(1): 5-7.
[9]	De FR, Bosch J, Garcia-Tsao G, et al. BavenoⅦ-Renewing consensus in portal hypertension[J]. Journal of Hepatology, 2022,76(4):959-974.
[10]	Bazarbashi AN, Ryou M. Gastric variceal bleeding[J]. Current Opinion in Gastroenterology, 2019, 35(6): 524-534.
[11]	Kiyosue H, Mori H, Matsumoto S, et al. Transcatheter obliteration of gastric varices: part 1. Anatomic classification[J]. Radiographics, 2003, 23(4): 911-920.
[12]	Wu Q, Shen L, Chu J, et al. Characterization of uncommon portosystemic collateral circulations in patients with hepatic cirrhosis[J]. Oncology Letters, 2015, 9(1): 347-350.
[13]	Araki T, Imaizumi A, Okada H, et al. Anatomy of left inferior phrenic vein in patients without portal hypertension[J]. American Journal of Roentgenology, 2021, 217(2): 411-417.
[14]	Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices[J]. Gastrointestinal endoscopy, 1986, 32(4): 264-268.
[15]	Abdel-Wahab M, El-Ebidy G, Gad El-Hak N, et al. Fundal varices: problem and management[J]. Hepato-gastroenterology, 1999, 46(26): 849-854.
[16]	Greig J, Garden O, Anderson J, et al. Management of gastric variceal haemorrhage[J]. British Journal of Surgery, 1990, 77(3): 297-299.
[17]	曹家伟, 丁鹏绪, 段峰, 等. 中国门静脉高压经颈静脉肝内门体分流术临床实践指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2694-2699.
[18]	Saad WE, Kitanosono T, Koizumi J. Balloon-occluded antegrade transvenous obliteration with or without balloon-occluded retrograde transvenous obliteration for the management of gastric varices: concept and technical applications[J]. Techniques in Vascular and Interventional Radiology, 2012, 15(3): 203-225.
[19]	Hirota S, Kobayashi K, Kako Y, et al. Balloon-occluded retrograde transvenous obliteration of varices: focusing on the portal hemodynamics and the recent techniques[J]. Hepatology International, 2018, 12(1): 102-111.
[20]	Gwon DI, Ko GY, Yoon HK, et al. Gastric varices and hepatic encephalopathy: treatment with vascular plug and gelatin sponge–assisted retrograde transvenous obliteration—a primary report[J]. Radiology, 2013, 268(1): 281-287.
[21]	Gwon DI, Kim YH, Ko GY, et al. Vascular plug–assisted retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy: a prospective multicenter study[J]. Journal of Vascular and Interventional Radiology, 2015, 26(11): 1589-1595.
[22]	Kim YH, Kim CS, Kang UR, et al. Comparison of balloon-occluded retrograde transvenous obliteration (BRTO) using ethanolamine oleate (EO), BRTO using sodium tetradecyl sulfate (STS) foam and vascular plug-assisted retrograde transvenous obliteration (PARTO)[J]. Cardiovascular and Interventional Radiology, 2016, 39(6): 840-846.
[23]	Parikh R. Balloon-occluded retrograde transvenous obliteration (BRTO)[M]. Essential Interventional Radiology Review. Springer, 2022: 529-548.
[24]	Waguri N, Osaki A, Watanabe Y. Balloon-occluded retrograde transvenous obliteration for treatment of gastric varices[J]. World Journal of Hepatology, 2021, 13(6): 650-661.
[25]	Tamai Y, Tanaka H, Fujimori M, et al. Successful endoscopic cyanoacrylate injection therapy for ruptured duodenal varices immediately after balloon-occluded retrograde transvenous obliteration[J]. JGH Open, 2021, 5(12): 1401-1403.
[26]	Lee EW, Saab S, Kaldas F, et al. Coil-assisted retrograde transvenous obliteration (CARTO): an alternative treatment option for refractory hepatic encephalopathy[J]. Official journal of the American College of Gastroenterology\| ACG, 2018, 113(8): 1187-1196.
[27]	Yamamoto A, Jogo A, Kageyama K, et al. Utility of coil-assisted retrograde transvenous obliteration II (CARTO-II) for the treatment of gastric varices[J]. Cardiovascular and Interventional Radiology, 2020, 43(4): 565-571.
[28]	Jogo A, Yamamoto A, Kaminoh T, et al. Utility of low-dose gelatin sponge particles and 5% ethanolamine oleate iopamidol mixture in retrograde transvenous obliteration (GERTO) for gastric varices[J]. The British Journal of Radiology, 2020, 93(1108): 20190751.
[29]	Kobayakawa M, Kokubu S, Hirota S, et al. Short-term safety and efficacy of balloon-occluded retrograde transvenous obliteration using ethanolamine oleate: results of a prospective, multicenter, single-arm trial[J]. Journal of Vascular and Interventional Radiology, 2017, 28(8): 1108-15. e2.
[30]	Farah MH, Nayfeh T, Urtecho M, et al. A systematic review supporting the Society for Vascular Surgery, the American Venous Forum, and the American Vein and Lymphatic Society guidelines on the management of varicose veins[J]. J Vasc Surg Venous Lymphat Disord, 2022, 10(5):1155-1171.
[31]	Sabri SS, Swee W, Turba UC, et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam[J]. Journal of Vascular and Interventional Radiology, 2011, 22(3): 309-316.
[32]	Choi SY, Won JY, Kim KA, et al. Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO)[J]. European Radiology, 2011, 21(1): 122-129.
[33]	万静. 内镜下聚桂醇与组织胶联合治疗食管胃底静脉曲张的效果观察[J]. 中国临床实用医学, 2021, 12(6): 30-33.
[34]	Luo X, Xiang T, Wu J, et al. Endoscopic cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration for prevention of gastric variceal bleeding: a randomized controlled trial[J]. Hepatology, 2021, 74(4): 2074-2084.
[35]	Tatsumi A, Maekawa S, Osawa L, et al. Spontaneous portosystemic shunt diameter predicts liver function after balloon-occluded retrograde transvenous obliteration[J]. JGH Open, 2022, 6(2): 139-147.
[36]	Yu Q, Liu C, Raissi D. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for gastric varices: a meta-analysis[J]. Journal of Clinical Gastroenterology, 2021, 55(2): 147-158.
[37]	彭伦华, 王运兵, 郭灿. 球囊阻断逆行经静脉闭塞对比经颈静脉肝内门体分流治疗门脉高压胃底静脉曲张出血的Meta分析[J]. 介入放射学杂志, 2016, 25(10): 843-848.
[38]	Paleti S, Nutalapati V, Fathallah J, et al. Balloon-occluded retrograde transvenous obliteration (BRTO) versus transjugular intrahepatic portosystemic shunt (TIPS) for treatment of gastric varices because of portal hypertension: a systematic review and meta-analysis[J]. Journal of Clinical Gastroenterology, 2020, 54(7): 655-660.
[39]	Ninoi T, Nishida N, Kaminou T, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients[J]. Ajr Am J Roentgenol, 2005, 184(4): 1340-1346.
[40]	Lee SJ, Kim SU, Kim MD, et al. Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis[J]. Journal of Gastroenterology and Hepatology, 2017, 32(8): 1487-1494.
[41]	Gimm G, Chang Y, Kim HC, et al. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for the management of gastric variceal bleeding[J]. Gut and liver, 2018, 12(6): 704.
[42]	Miyamoto Y, Oho K, Kumamoto M, et al. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension[J]. Journal of gastroenterology and hepatology, 2003, 18(8): 934-942.
[43]	Mukund A, Rajesh S, Arora A, et al. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience[J]. Journal of Vascular and Interventional Radiology, 2012, 23(9): 1200-1206.
[44]	Mukund A, Chalamarla LK, Singla N, et al. Intractable hepatic encephalopathy in cirrhotic patients: mid-term efficacy of balloon-occluded retrograde portosystemic shunt obliteration[J]. European Radiology, 2020, 30(6): 3462-3472.
[45]	Luo X, Ma H, Yu J, et al. Efficacy and safety of balloon-occluded retrograde transvenous obliteration of gastric varices with lauromacrogol foam sclerotherapy: initial experience[J]. Abdominal Radiology, 2018, 43(7): 1820-1824.
[46]	Mukund A, Deogaonkar G, Rajesh S, et al. Safety and efficacy of sodium tetradecyl sulfate and lipiodol foam in balloon-occluded retrograde transvenous obliteration (BRTO) for large porto-systemic shunts[J]. CardioVascular and Interventional Radiology, 2017, 40(7): 1010-1016.
[47]	Inoue H, Emori K, Toyonaga A, et al. Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension[J]. The Kurume Medical Journal, 2014: MS63014.
[48]	Mukund A, Rangarh P, Shasthry SM, et al. Salvage balloon occluded retrograde transvenous obliteration for gastric variceal bleed in cirrhotic patients with endoscopic failure to control bleed/very early rebleed: long-term outcomes[J]. Journal of Clinical and Experimental Hepatology, 2020, 10(5): 421-428.
[49]	Saad WE. Balloon-occluded retrograde transvenous obliteration of gastric varices: concept, basic techniques, and outcomes[J]. Semin Intervent Radiol, 2012, 29(2): 118-128.
[50]	Saad WE, Darcy MD. Transjugular intrahepatic portosystemic shunt (TIPS) versus balloon-occluded retrograde transvenous obliteration (BRTO) for the management of gastric varices[J]. Semin Intervent Radiol, 2011, 28(3): 339-349.
[51]	罗薛峰. 介入治疗胃静脉曲张:过去,现在和将来[J]. 中华介入放射学电子杂志, 2019, 7(2): 95-100.
[52]	Sarin SK, Jain AK, Jain M, et al. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices[J]. The American Journal of Gastroenterology, 2002, 97(4): 1010-1015.
[53]	Lo GH, Lai KH, Cheng JS, et al. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices[J]. Hepatology, 2001, 33(5): 1060-1064.
[54]	Tan PC, Hou MC, Lin HC, et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation[J]. Hepatology, 2006, 43(4): 690-697.
[55]	Rengstorff DS, Binmoeller KF. A pilot study of 2-octyl cyanoacrylate injection for treatment of gastric fundal varices in humans[J]. Gastrointestinal Endoscopy, 2004, 59(4): 553-558.
[56]	Stein DJ, Salinas C, Sabri S, et al. Balloon retrograde transvenous obliteration versus endoscopic cyanoacrylate in bleeding gastric varices: comparison of rebleeding and mortality with extended follow-up[J]. Journal of Vascular and Interventional Radiology, 2019, 30(2): 187-194.
[57]	Kim SK, Lee KA, Sauk S, et al. Comparison of transjugular intrahepatic portosystemic shunt with covered stent and balloon-occluded retrograde transvenous obliteration in managing isolated gastric varices[J]. Korean Journal of Radiology, 2017, 18(2): 345-354.
[58]	Wang ZW, Liu JC, Zhao F, et al. Comparison of the effects of TIPS versus BRTO on bleeding gastric varices: a meta-analysis[J].CanJ Gastroenterol Hepatol, 2020: 5143013.
[59]	Liu J, Yang C, Huang S, et al. The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage[J]. European Journal of Gastroenterology & Hepatology, 2020, 32(5): 656.
[60]	Ishikawa T, Hamamoto K, Sasaki R, et al. Significant improvement in portal-systemic liver failure symptoms and successful management of portal-splenic venous hemodynamics by the combination of interventional radiology and pharmacotherapy[J]. Hepatology Research, 2020, 50(10): 1201-1208.
[61]	Iwamoto T, Saeki I, Hidaka I, et al. Novel therapeutic strategy using interventional radiology (IVR) for hepatitis C virus (HCV)-related decompensated liver cirrhosis: a case report[J]. The American Journal of Case Reports, 2019, 20: 1699.
[62]	Talwar A, Gabr A, Riaz A, et al. Adverse events related to partial splenic embolization for the treatment of hypersplenism: a systematic review[J]. Journal of Vascular and Interventional Radiology, 2020, 31(7): 1118-1131. e6.
[63]	Sakai T, Shiraki K, Inoue H, et al. Complications of partial splenic embolization in cirrhotic patients[J]. Digestive Diseases and Sciences, 2002, 47(2): 388-391.

Please choose a citation manager

Content to export